Dragonfly Energy Holdings has seen its fair value estimate leap from $1.88 to $18.75 per share, even as the discount rate guiding that valuation has nudged higher from 11.53% to 12.50% and revenue ...

Gilead Sciences has made another foray into the natural killer (NK) cell category, paying $300 million upfront to access Dragonfly Therapeutics' TriNKET platform to find therapies for cancer and ...

Bristol-Myers Squibb has signed an agreement worth $475 million to develop a new form of cancer immunotherapy drug with US biotech Dragonfly Therapeutics. BMS is best known as an early pioneer of ...

Dragonfly Energy Holdings Corp. engages in the manufacturing and sale of deep cycle lithium-ion batteries for recreational vehicles, marine vessels, solar and off-grid residence industries, and ...

Beads from Must Farm made of amber, siltstone, shale, tin, and faience (top row), and glass (second and third rows) The majority of the beads are blue and green glass—the largest collection of glass ...